Pandion Raises $80 Million Series B to Advance Autoimmune Therapies

Pandion Therapeutics, based in Cambridge, Massachusetts, closed an $80 million Series B financing. The round was led by Access Biotechnology and Boxer Capital. It included new investors RA Capital and OrbiMed. Existing investors also participated including Polaris Partners, Versant Ventures, Roche Venture Fund, SR One, JDRF T1D Fund and BioInnovation Capital.